United States
# |
Name |
EBITDA |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 11.31 B
|
Sept. 28, 2024 | USD 556.99 | 0.27% |
|
United States |
|
2 |
USD 10.76 B
|
Sept. 30, 2024 | USD 113.02 | -0.15% |
|
United States |
|
3 |
USD 5.48 B
|
Sept. 30, 2024 | USD 362.80 | 0.50% |
|
United States |
|
4 |
USD 4.26 B
|
Sept. 30, 2024 | USD 235.80 | -0.17% |
|
United States |
|
5 |
USD 3.73 B
|
Sept. 30, 2024 | USD 95.65 | 1.10% |
|
United States |
|
6 |
USD 3.58 B
|
Sept. 30, 2024 | USD 84.13 | -1.40% |
|
United States |
|
7 |
USD 2.51 B
|
Sept. 30, 2024 | USD 104.71 | -0.74% |
|
United States |
|
8 |
USD 2.51 B
|
Sept. 30, 2024 | USD 538.88 | -0.16% |
|
United States |
|
9 |
USD 2.11 B
|
Sept. 30, 2024 | USD 179.15 | 1.50% |
|
United States |
|
10 |
USD 1.79 B
|
Sept. 30, 2024 | USD 70.19 | 2.45% |
|
United States |
|
11 |
USD 1.70 B
|
Sept. 30, 2024 | USD 71.04 | -0.07% |
|
United States |
|
12 |
USD 1.69 B
|
Sept. 30, 2024 | USD 228.83 | -0.62% |
|
United States |
|
13 |
USD 1.30 B
|
Sept. 28, 2024 | USD 70.20 | -0.13% |
|
United States |
|
14 |
USD 1.17 B
|
Sept. 30, 2024 | USD 1.27 K | 0.33% |
|
United States |
|
15 |
USD 975.30 M
|
Sept. 30, 2024 | USD 79.17 | -0.84% |
|
United States |
|
16 |
USD 811.39 M
|
Sept. 30, 2024 | USD 210.46 | -1.51% |
|
United States |
|
17 |
USD 652.18 M
|
Sept. 30, 2024 | USD 92.62 | -2.15% |
|
United States |
|
18 |
USD 636.02 M
|
Sept. 29, 2024 | USD 179.17 | 0.35% |
|
United States |
|
19 |
USD 610.70 M
|
Sept. 30, 2024 | USD 65.65 | -1.41% |
|
United States |
|
20 |
USD 533.60 M
|
Sept. 30, 2024 | USD 61.26 | -2.69% |
|
United States |
|
21 |
USD 517.61 M
|
Sept. 30, 2024 | USD 88.18 | 1.15% |
|
United States |
|
22 |
USD 428.80 M
|
Sept. 30, 2024 | USD 267.04 | -0.35% |
|
United States |
|
23 |
USD 349.00 M
|
Sept. 30, 2024 | USD 111.11 | 1.26% |
|
United States |
|
24 |
USD 322.25 M
|
Sept. 30, 2024 | USD 10.37 | 0.39% |
|
United States |
|
25 |
USD 313.15 M
|
Sept. 27, 2024 | USD 138.83 | 2.72% |
|
United States |
|
26 |
USD 288.32 M
|
Sept. 30, 2024 | USD 99.89 | 4.44% |
|
United States |
|
27 |
USD 273.52 M
|
Sept. 28, 2024 | USD 79.96 | 0.69% |
|
United States |
|
28 |
USD 256.80 M
|
Sept. 30, 2024 | USD 161.08 | 1.85% |
|
United States |
|
29 |
USD 246.69 M
|
Sept. 30, 2024 | USD 67.79 | -2.46% |
|
United States |
|
30 |
USD 233.70 M
|
Sept. 30, 2024 | USD 21.93 | -1.62% |
|
United States |
|
31 |
USD 225.30 M
|
Sept. 30, 2024 | USD 20.10 | 0.95% |
|
United States |
|
32 |
USD 217.10 M
|
Sept. 28, 2024 | USD 166.09 | 0.31% |
|
United States |
|
33 |
USD 212.34 M
|
Sept. 30, 2024 | USD 50.77 | 2.13% |
|
United States |
|
34 |
USD 164.50 M
|
Sept. 30, 2024 | USD 16.29 | 2.65% |
|
United States |
|
35 |
USD 161.73 M
|
Sept. 27, 2024 | USD 148.22 | 1.40% |
|
United States |
|
36 |
USD 96.60 M
|
Sept. 30, 2024 | USD 15.83 | 0.19% |
|
United States |
|
37 |
USD 65.83 M
|
Sept. 30, 2024 | USD 3.05 | -0.33% |
|
United States |
|
38 |
USD 62.60 M
|
Sept. 27, 2024 | USD 13.52 | 1.05% |
|
United States |
|
39 |
USD 60.35 M
|
Sept. 30, 2024 | USD 95.85 | 1.78% |
|
United States |
|
40 |
USD 58.14 M
|
Sept. 30, 2024 | USD 62.54 | -2.36% |
|
United States |
|
41 |
USD 43.19 M
|
Sept. 30, 2024 | USD 13.47 | -1.25% |
|
United States |
|
42 |
USD 42.61 M
|
Sept. 30, 2024 | USD 8.00 | 1.01% |
|
United States |
|
43 |
USD 40.05 M
|
Sept. 28, 2024 | USD 22.64 | 0.85% |
|
United States |
|
44 |
USD 35.91 M
|
Sept. 28, 2024 | USD 105.78 | 2.21% |
|
United States |
|
45 |
USD 33.77 M
|
Sept. 30, 2024 | USD 252.89 | 2.41% |
|
United States |
|
46 |
USD 32.28 M
|
Sept. 28, 2024 | USD 8.87 | -3.17% |
|
United States |
|
47 |
USD 28.13 M
|
Sept. 30, 2024 | USD 17.46 | 1.51% |
|
United States |
|
48 |
USD 25.71 M
|
Sept. 30, 2024 | USD 15.16 | 0.20% |
|
United States |
|
49 |
USD 22.77 M
|
Sept. 30, 2024 | USD 57.52 | 1.79% |
|
United States |
|
50 |
USD 20.21 M
|
Sept. 30, 2024 | USD 54.93 | 4.23% |
|
United States |
The Medical Instruments company in United States with the highest EBITDA is Thermo Fisher Scientific Inc. (NYSE: TMO) at USD 11.31 B.
The Medical Instruments company in United States with the lowest EBITDA is Heart Test Laboratories, Inc. (NasdaqCM: HSCS) at USD -1.99 B.
The top 10 Medical Instruments companies in United States by EBITDA are Thermo Fisher Scientific Inc., Abbott Laboratories, Stryker Corporation, Becton, Dickinson and Company, Boston Scientific Corporation, GE HealthCare Technologies Inc., Zimmer Biomet Holdings, Inc., Intuitive Surgical, Inc., AMETEK, Inc. and Solventum Corporation.
The bottom 10 Medical Instruments companies in United States by EBITDA are Heart Test Laboratories, Inc., QuidelOrtho Corporation, Mesa Laboratories, Inc., 10x Genomics, Inc., Standard BioTools Inc., Outset Medical, Inc., iRhythm Technologies, Inc., Tandem Diabetes Care, Inc., Butterfly Network, Inc. and Enovis Corporation.